Research Report Identifies Brady, RA PHARMCTL INC, Sigma Designs, Teva Pharmaceutical Industries, Bridge, and BOK Financial with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

Research Report Identifies Brady, RA PHARMCTL INC, Sigma Designs, Teva Pharmaceutical Industries, Bridge, and BOK Financial with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

NEW YORK, May 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Brady Corporation (NYSE:BRC), RA PHARMCTL INC (NASDAQ:RARX), Sigma Designs, Inc. (NASDAQ:SIGM), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Bridge Bancorp, Inc. (NASDAQ:BDGE), and BOK Financial Corporation (NASDAQ:BOKF), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

BRC DOWNLOAD: http://Fundamental-Markets.com/register/?so=BRC
RARX DOWNLOAD: http://Fundamental-Markets.com/register/?so=RARX
SIGM DOWNLOAD: http://Fundamental-Markets.com/register/?so=SIGM
TEVA DOWNLOAD: http://Fundamental-Markets.com/register/?so=TEVA
BDGE DOWNLOAD: http://Fundamental-Markets.com/register/?so=BDGE
BOKF DOWNLOAD: http://Fundamental-Markets.com/register/?so=BOKF

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Brady Corporation (NYSE:BRC), RA PHARMCTL INC (NASDAQ:RARX), Sigma Designs, Inc. (NASDAQ:SIGM), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Bridge Bancorp, Inc. (NASDAQ:BDGE), and BOK Financial Corporation (NASDAQ:BOKF) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed May 22nd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

BRADY CORPORATION (BRC) REPORT OVERVIEW

Brady's Recent Financial Performance

For the three months ended January 31st, 2018 vs January 31st, 2017, Brady reported revenue of $287.78MM vs $268.00MM (up 7.38%) and basic earnings per share $0.08 vs $0.50 (down 84.00%). For the twelve months ended July 31st, 2017 vs July 31st, 2016, Brady reported revenue of $1,113.32MM vs $1,120.63MM (down 0.65%) and basic earnings per share $1.86 vs $1.57 (up 18.47%). Brady is expected to report earnings on May 24th, 2018. The report will be for the fiscal period ending April 30th, 2018. The reported EPS for the same quarter last year was $0.43.

To read the full Brady Corporation (BRC) report, download it here: http://Fundamental-Markets.com/register/?so=BRC

-----------------------------------------

RA PHARMCTL INC (RARX) REPORT OVERVIEW

RA PHARMCTL INC's Recent Financial Performance

RA PHARMCTL INC is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.56. The estimated EPS forecast for the next fiscal year is -$2.10 and is expected to report on March 13th, 2019.

To read the full RA PHARMCTL INC (RARX) report, download it here: http://Fundamental-Markets.com/register/?so=RARX

-----------------------------------------

SIGMA DESIGNS, INC. (SIGM) REPORT OVERVIEW

Sigma Designs' Recent Financial Performance

For the three months ended January 31st, 2018 vs January 31st, 2017, Sigma Designs reported revenue of -$47.03MM vs -$43.41MM and basic earnings per share -$1.91 vs -$0.23. For the twelve months ended January 31st, 2018 vs January 31st, 2017, Sigma Designs reported revenue of $65.91MM vs $134.41MM (down 50.97%) and basic earnings per share -$3.12 vs -$0.49. Sigma Designs is expected to report earnings on June 5th, 2018. The report will be for the fiscal period ending April 30th, 2018.

To read the full Sigma Designs, Inc. (SIGM) report, download it here: http://Fundamental-Markets.com/register/?so=SIGM

-----------------------------------------

TEVA PHARMACEUTICAL INDUSTRIES LTD. (TEVA) REPORT OVERVIEW

Teva Pharmaceutical Industries' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Teva Pharmaceutical Industries reported revenue of $5,065.00MM vs $5,650.00MM (down 10.35%) and basic earnings per share $1.04 vs $0.57 (up 82.46%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Teva Pharmaceutical Industries reported revenue of $22,385.00MM vs $21,903.00MM (up 2.20%) and basic earnings per share -$16.26 vs $0.07. Teva Pharmaceutical Industries is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.99. The estimated EPS forecast for the next fiscal year is $2.46 and is expected to report on February 14th, 2019.

To read the full Teva Pharmaceutical Industries Ltd. (TEVA) report, download it here: http://Fundamental-Markets.com/register/?so=TEVA

-----------------------------------------

BRIDGE BANCORP, INC. (BDGE) REPORT OVERVIEW

Bridge's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Bridge reported interest income of $41.36MM vs $35.22MM (up 17.45%) and basic earnings per share $0.61 vs $0.47 (up 29.79%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Bridge reported interest income of $149.85MM vs $137.72MM (up 8.81%) and basic earnings per share $1.04 vs $2.01 (down 48.26%). Bridge is expected to report earnings on July 25th, 2018. The report will be for the fiscal period ending June 30th, 2018.

To read the full Bridge Bancorp, Inc. (BDGE) report, download it here: http://Fundamental-Markets.com/register/?so=BDGE

-----------------------------------------

BOK FINANCIAL CORPORATION (BOKF) REPORT OVERVIEW

BOK Financial's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, BOK Financial reported interest income of $265.41MM vs $226.39MM (up 17.23%) and basic earnings per share $1.61 vs $1.35 (up 19.26%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, BOK Financial reported interest income of $972.75MM vs $829.12MM (up 17.32%) and basic earnings per share $5.11 vs $3.53 (up 44.76%). BOK Financial is expected to report earnings on July 25th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.35. The estimated EPS forecast for the next fiscal year is $6.99 and is expected to report on January 23rd, 2019.

To read the full BOK Financial Corporation (BOKF) report, download it here: http://Fundamental-Markets.com/register/?so=BOKF

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.